Online patient-provider cannabis consultations

Publication date: Available online 15 January 2020Source: Preventive MedicineAuthor(s): Kathleen Gali, Ruth Narode, Kelly C. Young-Wolff, Mark L. Rubinstein, Geoffrey Rutledge, Judith J. ProchaskaAbstractCannabis has been legalized, decriminalized, or medicalized in over half the U.S. states. With restrictions on cannabis research, accepted standards to guide clinical practice are lacking. Analyzing online communications through a digital health platform, we characterized patient questions about cannabis use and provider responses. Coded for content were 4579 questions posted anonymously online between March 2011 through January 2017, and the responses from 1,439 U.S. licensed clinicians. Provider responses to medical cannabis use questions were coded for sentiment: “negative”, “positive”, and “mixed.” Responses could be “thanked” by patients and receive “agrees” from providers. The most frequent themes were detection of cannabis use (25.3%), health harms (19.9%), co-use with other substances (9.1%), and medical use (8.2%). The 425 medical cannabis use questions most frequently related to treatment of mental illness (20.3%), pain (20.0%), and cancer care (6.7%). The 762 provider responses regarding medical cannabis use were coded for sentiment as 59.5% negative, 28.6% mixed, and 11.8% positive. Provider sentiment was most positive regarding cannabis use for palliative care and most negative for treating respiratory c...
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research

Related Links:

In this narrative medicine essay, a pediatric palliative oncologist meditates on the intersection of faith and medicine and of varying expressions of spirituality in the face of abject pain and suffering among her pediatric patients with cancer.
Source: JAMA - Category: General Medicine Source Type: research
CONCLUSIONS: Patient and illness factors were not associated with needs among those who attended appointments with support providers. Study results suggest that a biopsychosocial approach from interdisciplinary providers is warranted to manage the needs of patients referred for additional supportive care. PMID: 32066250 [PubMed - as supplied by publisher]
Source: The American Journal of Hospice and Palliative Care - Category: Palliative Care Authors: Tags: Am J Hosp Palliat Care Source Type: research
Transcutaneous electrical nerve stimulation (TENS) is primarily used for pain, but might be useful for various other physical symptoms, including nausea, fatigue, dyspnea, and constipation. However, few studies have used TENS for treating the physical symptoms of patients with advanced cancer. In this crossover trial, we assess the effects of TENS on pain and other physical symptoms in 20 in-patients with advanced cancer receiving palliative care. For 5-day phases between wash out periods of 5 days, patients received TENS or non-TENS. TENS was delivered at four points: the center of the back for mainly nausea and dyspnea, ...
Source: International Journal of Rehabilitation Research - Category: Rehabilitation Tags: Original Articles Source Type: research
CONCLUSION: pain in palliative patients is mainly experienced by cancer patients and the elderly. Psychological factors affect the condition of pain, so the management that includes biopsychosocial aspect will be able to reduce pain significantly. PMID: 32041912 [PubMed - in process]
Source: Acta medica Indonesiana - Category: Internal Medicine Tags: Acta Med Indones Source Type: research
CONCLUSION: Accurate prognostic awareness may pose harm and may provide no additional benefits in terms of QoL and mood among patients with advanced cancer for a short period of time. PMID: 32052654 [PubMed - as supplied by publisher]
Source: The American Journal of Hospice and Palliative Care - Category: Palliative Care Authors: Tags: Am J Hosp Palliat Care Source Type: research
Patients and caregivers both had better outcomes when palliative care was integrated into their care Related items fromOnMedica Fund specialist dementia training to improve care and save money Emergency admissions at end of life set to sky rocket One in two women and one in three men will develop neurological disease Poor people have worse end-of-life care Cannabinoids not recommended to treat cancer-related pain
Source: OnMedica Latest News - Category: UK Health Source Type: news
The challenges facing people with Parkinson disease (PD) become increasingly complex as the disease advances. Despite optimal medical treatment, many individuals experience mounting unmet needs, including problems with mobility and cognition. This situation occurs perhaps because most management approaches revolve around disease-based models, which tend to disregard the person and family living with the disease. It is therefore worthwhile to consider alternative approaches. One option is palliative care, which is a holistic way of looking at a person and family in the context of a serious illness. The World Health Organiza...
Source: JAMA Neurology - Category: Neurology Source Type: research
CONCLUSION: We present a case that underlines the importance of specialized PC assessment not limited to the control of symptoms. The search for the etiopathogenesis of a patient's symptoms and the evaluation of overall clinical conditions may be necessary to plan appropriate diagnostic evaluations, target palliative therapies, and achieve effective symptom control. PMID: 32008478 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
Madam — Historically, effective systemic treatments for men diagnosed with advanced or metastatic prostate cancer were limited. Most would experience an initial but temporary symptomatic and biochemical response to castration-based therapy with either bilateral orchidectomy or luteinising hormone-releas ing hormone agonists. At this stage, the addition of antiandrogens, steroids, stilboestrol or chemotherapy with mitoxantrone could be considered. These agents had short-lived benefits with no improvement in survival and limited symptomatic or palliative response for bone pain.
Source: Clinical Oncology - Category: Radiology Authors: Tags: Letter Source Type: research
This study aimed to investigate the survival outcome of PTR in patients who received palliative bevacizumab-containing chemotherapy (BCT). From January 2006 to December 2018, medical records of 240 mCRC patients who received palliative BCT at a single tertiary colorectal cancer center were retrospectively reviewed. Patients were classified into three groups: PTR-a (PTR before BCT, n = 60), PTR-b (PTR during BCT, n = 17), and BCT-only group (n = 163). Resectable mCRCs or recurrent diseases were excluded, and the end-point was overall survival (OS) rate. Three groups had similar age, cell differentiation, locat...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research
More News: Cancer | Cancer & Oncology | International Medicine & Public Health | Legislation | Men | Pain | Palliative | Palliative Care | Respiratory Medicine